KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (2016 - 2025)

Johnson & Johnson's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $2.09 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 48.23% year-over-year to $2.09; the TTM value through Dec 2025 reached $11.03, up 90.5%, while the annual FY2025 figure was $11.03, 90.5% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.09 at Johnson & Johnson, down from $2.11 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $10.21 in Q4 2023 and bottomed at -$0.21 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is $1.78 (2022), against an average of $2.04.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 310.0% in 2023 before it soared 4566.67% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.37 in 2021, then rose by 18.25% to $1.62 in 2022, then crashed by 112.96% to -$0.21 in 2023, then surged by 771.43% to $1.41 in 2024, then surged by 48.23% to $2.09 in 2025.
  • Per Business Quant, the three most recent readings for JNJ's EPS (Weighted Average and Diluted) are $2.09 (Q4 2025), $2.11 (Q3 2025), and $2.29 (Q2 2025).